Lifetime Incidence of CKD Stages 3-5 in the United States

Slides:

Advertisements

Similar presentations

The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.

Advertisements

Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD

Differential Estimation of CKD Using Creatinine- Versus Cystatin C–Based Estimating Equations by Category of Body Mass Index Suma Vupputuri, PhD, Caroline.

Cystatin C and Albuminuria as Risk Factors for Development of CKD Stage 3: The Multi- Ethnic Study of Atherosclerosis (MESA) Shani Shastri, MD, MS, Ronit.

Uric Acid and Long-term Outcomes in CKD

KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,

Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,

Metabolic Complications in Elderly Adults With CKD

Development of Reduced Kidney Function in Rheumatoid Arthritis

Jessica W. Weiss, MD, Eric S. Johnson, PhD, Amanda Petrik, MS, David H

Care of the Undocumented Immigrant in the United States With ESRD

Francesca Mallamaci, MD, Giovanni Tripepi, PhD

Association of Physical Activity and Renal Function in Subjects With and Without Metabolic Syndrome: A Review of the Third National Health and Nutrition.

A Decade After the KDOQI CKD Guidelines

World Kidney Day 2014: CKD and the Aging Population

Joseph A. Vassalotti, MD, Beth Piraino, MD, Lynda A. Szczech, MD

Cardiovascular Disease and CKD: Core Curriculum 2010

Impact of Comorbidities on Mortality in Managed Care Patients With CKD

Recognition for Conservative Care in Kidney Failure

Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP) Richard.

A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome

Anne M. Butler, PhD, Andrew F. Olshan, PhD, Abhijit V

Andrew Narva American Journal of Kidney Diseases

Evaluation of the Potential Living Kidney Donor

Hai-yan Wang, MD, American Journal of Kidney Diseases

Focusing on Health Literacy Might Help Us Cross the Quality Chasm

Comprehensive Public Health Strategies for Preventing the Development, Progression, and Complications of CKD: Report of an Expert Panel Convened by the.

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Guidelines for the Older Adult With CKD

Cerebrovascular Disease Incidence, Characteristics, and Outcomes in Patients Initiating Dialysis: The Choices for Healthy Outcomes in Caring for ESRD.

The Kidney Early Evaluation Program (KEEP): Program Design and Demographic Characteristics of the Population Claudine T. Jurkovitz, MD, MPH, Yang Qiu,

Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S

Navdeep Tangri, MD, FRCPC, Daniel E. Weiner, MD, MS

A Decade After the KDOQI CKD Guidelines: A Historical Perspective

David C. Mendelssohn, MD, FRCPC, Jay B. Wish, MD

Usability Testing and Acceptance of an Electronic Medication Inquiry System for CKD Patients Clarissa J. Diamantidis, MD, MHS, Marni Zuckerman, MA, Wanda.

Julie A. Wright Nunes, MD, MPH, Kerri L

Volume 87, Issue 4, Pages (April 2015)

Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study Eric D.

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

Nephrology: As It Was Then, But Is Not Now

Volume 70, Issue 12, Pages (December 2006)

Beef Tea, Vitality, Creatinine, and the Estimated GFR

A Timely Evaluation of the Psychometric Properties of the KDQOL-36

American Journal of Kidney Diseases

Quiz Page April 2008 American Journal of Kidney Diseases

Study Designs in Patient-Oriented Research

Evidence and Outcomes in CKD

Within-Person Variability in Kidney Measures

Daniel T. Lackland, DrPH, David J.P. Barker, MD, PhD

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

Quiz Page August 2007 American Journal of Kidney Diseases

Risk for Incident Renal Dialysis in a Managed Care Population

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Lesley A. Stevens, MD, MS, Josef Coresh, MD, PhD, Andrew S. Levey, MD

Trial Quality in Nephrology: How Are We Measuring Up?

Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm David P. Calfee, MD, MS American Journal of Kidney.

Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), Madhav V. Rao,

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Commentary on ‘The DOPPS Practice Monitor for US Dialysis Care: Potential Impact of Recent Guidelines and Regulatory Changes on Management of Mineral.

James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD

Dialysis Research and N-of-1 Trials: Made for Each Other?

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

Maristela Böhlke, PhD American Journal of Kidney Diseases

A Decade After the KDOQI CKD Guidelines: Impact on the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Adam Whaley-Connell, DO, MSPH

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Quiz page December 2003 American Journal of Kidney Diseases

Presentation transcript:

Lifetime Incidence of CKD Stages 3-5 in the United States Morgan E. Grams, MD, MHS, Eric K.H. Chow, MS, Dorry L. Segev, MD, PhD, Josef Coresh, MD, PhD American Journal of Kidney Diseases Volume 62, Issue 2, Pages 245-252 (August 2013) DOI: 10.1053/j.ajkd.2013.03.009 Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Markov chain model used to simulate the progression of an initially chronic kidney disease (CKD)-free individual through death or the development of CKD. Abbreviations: ICKD, 1-year probability of developing CKD; QCKD, 1-year probability of dying in an individual with CKD; QnoCKD, 1-year probability of dying prior to the development of CKD. Here, CKD is treated as a single outcome, representing the stage of interest (CKD 3a+, CKD 3b+, CKD 4+, or end-stage renal disease). Progression through CKD stages is not modeled. American Journal of Kidney Diseases 2013 62, 245-252DOI: (10.1053/j.ajkd.2013.03.009) Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions

Figure 2 Cumulative incidence from birth by race and sex of chronic kidney disease (CKD) stage (A) 3a+, (B) 3b+, (C) 4+, and (D) end-stage renal disease (ESRD). American Journal of Kidney Diseases 2013 62, 245-252DOI: (10.1053/j.ajkd.2013.03.009) Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions

Figure 3 Chronic kidney disease (CKD) stage 3a+ projections by age, race, and sex, scaled by estimated 2012 US population. American Journal of Kidney Diseases 2013 62, 245-252DOI: (10.1053/j.ajkd.2013.03.009) Copyright © 2013 National Kidney Foundation, Inc. Terms and Conditions